Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 4, 2011, Pages 561-564

  Pankey, George A ^a   Ashcraft, Deborah S ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Klebsiella; KPC; Meropenem; Polymyxin B; Rifampin; Synergy

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEMASE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; RIFAMPICIN; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL GENETICS; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENTIATION; EPSILOMETER TEST; INTERMETHOD COMPARISON; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TIME KILL ASSAY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG SYNERGISM; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; POLYMYXIN B; RIFAMPIN; THIENAMYCINS; TIME FACTORS;

EID: 79960345860     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.05.003     Document Type: Article

References (22)

1. Bratu S., Tolaney P., Karumudi U., Quale J., Mooty M., Nichani S., Landman D. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J. Antimicrob. Chemother. 2005, 56:128-132.
2. Bratu S., Mooty M., Nichani S., Landman D., Gullans C., Pettinato B., Karumudi U., Tolaney P., Quale J. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents. Chemother. 2005, 49:3018-3020.
3. Chen L.F., Kaye D. Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides. Infect. Dis. Clin. N. Am. 2009, 23:1053-1075.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement. M100-S21 2011, CLSI, Wayne, PA.
5. KPC-2 gene. Emerg. Infect. Dis. 2010, 16:1349-1356.
6. Elemam A., Rahimian J., Doymaz M. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. J. Clin. Microbiol. 2010, 48:3558-3562.
7. Gasink L., Edelstein P., Lautenbach E., Synnestvedt M., Fishman N. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect. Control. Hosp. Epidemiol. 2009, 30:1180-1185.
8. Guelfi K.C., Tognim M.C.B., Cardoso C.L., Gales A.C., Carrara-Marrone F.E., Garcia L.B. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii. J. Chemother. 2008, 20:180-185.
9. Kontopoulou K., Protonotariou E., Vasilakos K., Kriti M., Koteli A., Antoniadou E., Sofianou D. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J. Hosp. Infect. 2010, 76:70-73.
10. Lee J., Jenkins S. Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J. Clin. Microbiol. 2009, 47:1611-1612.
11. Marchaim D., Chopra T., Pogue J., Perez F., Hujer A., Rudin S., Endimiani A., Venezia Navon-S., Hothi J., Slim J., Blunden C., Shango M., Lephart P., Salimnia H., Reid D., Moshos J., Hafeez W., Bheemreddy S., Chen T., Dhar S., Bonomo R., Kaye K. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan. Antimicrob. Agents. Chemother. 2011, 55:593-599.
12. Mendes R.E., Kiyota K.A., Monteiro J., Castanheira M., Andrade S.S., Gales A.C., Pignatari A., Tufik S. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 2007, 45:544-547.
13. Moody J. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. Clinical microbiology procedures handbook 2010, 5.12.1-5.12.23. American Society for Microbiology, Washington, DC. 3rd ed. L. Garcia (Ed.).
14. National Committee for Clinical Laboratory Standards (NCCLS) Methods for determining bactericidal activity of antimicrobial agents; approved guideline. NCCLS document M26-A 1999, NCCLS, Wayne, PA.
15. Neuner E., Yeh J., Hall G., Sekeres J., Endimiani A., Bonomo R., Shrestha N., Fraser T., Duin D. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn. Microbiol. Infect. Dis. 2011, 69:357-362.
16. Pankey G.A., Ashcraft D.S. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. Antimicrob. Agents. Chemother. 2005, 49:2959-2964.
17. Pankey G.A., Ashcraft D.S. The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay. Diagn. Microbiol. Infect. Dis. 2009, 63:228-232.
18. Perez F., Endimiani A., Ray A., Decker B., Wallace C., Hujer K., Ecker D., Adams M., Toltzis P., Dul M., Windau A., Bajaksouzian S., Jacobs M., Salata R., Bonomo R. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J. Antimicrob. Chemother. 2010, 65:1807-1818.
19. Pillai S.K., Moellering R.C., Eliopoulos G.M. Antimicrobial combinations. Antibiotics in Laboratory Medicine 2005, 365-440. Lippincott Williams and Wilkins, Philadelphia, PA. 5th ed. V. Lorian (Ed.).
20. Suh J.Y., Son J.S., Chung D.R., Peck K.R., Ko K.S., Song J.H. Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob. Agents. Chemother. 2010, 54:560-562.
21. Tóth A., Damjanova I., Puskás E., Jánvári L., Farkas M., Dobák A., Böröcz K., Pászti J. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29:765-769.
22. Yoon J., Urban C., Terzian N., Mariano N., Rahal J. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents. Chemother. 2004, 48:753-757.